专题：Myeloproliferative Neoplasms: Diagnosis and Treatment

This cluster of papers focuses on the molecular pathogenesis, diagnosis, treatment, and prognosis of myeloproliferative disorders such as polycythemia vera, essential thrombocythemia, and myelofibrosis. It covers topics such as JAK2 and CALR mutations, prognostic scoring systems, ruxolitinib therapy, hematologic response, leukemic transformation, and stem cell transplantation.
最新文献
Interleukin-18 Inhibition Aggravates Atherosclerosis in Jak2 Clonal Hematopoiesis

article Full Text OpenAlex

A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia

article Full Text OpenAlex

Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy

article Full Text OpenAlex

Impact of autoimmune diseases or inflammatory manifestations on response and outcome in high-risk myelodysplastic syndromes and chronic myelomonocytic leukemia

article Full Text OpenAlex

Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms

article Full Text OpenAlex

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)

article Full Text OpenAlex

Deep Cerebral Vein Thrombosis Triggered by Contraceptive Use in a Woman with Non-Overt Essential Thrombocythemia

article Full Text OpenAlex

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms

article Full Text OpenAlex

TLR7 F507S gain-of-function mutation presenting with early-onset SLE and hypertriglyceridemia: Response to JAK inhibition

article Full Text OpenAlex

Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications

article Full Text OpenAlex

近5年高被引文献
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

review Full Text OpenAlex 3617 FWCI552.0255

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

article Full Text OpenAlex 2746 FWCI418.2692

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

article Full Text OpenAlex 2461 FWCI374.646

Journal of Thrombosis and Haemostasis

paratext Full Text OpenAlex 557 FWCI0

Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia

article Full Text OpenAlex 458 FWCI69.765

Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management

review Full Text OpenAlex 409 FWCI127.9874

Acute myeloid leukaemia

review Full Text OpenAlex 355 FWCI104.6901

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab

article Full Text OpenAlex 339 FWCI49.3968

Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis

article Full Text OpenAlex 332 FWCI50.1987

A Comprehensive Overview of Globally Approved JAK Inhibitors

review Full Text OpenAlex 301 FWCI29.6159